I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert whose extensive experience in research and development has positioned him at the forefront of innovation in the industry. Today, we’ll dive into his groundbreaking work on chromosome stability, focusing on the critical role of
In a landscape where rare diseases often linger in the shadows of medical research, autosomal dominant hypocalcemia Type 1 (AD#), a condition affecting calcium regulation, impacts thousands with limited treatment options. With an estimated 12,000 individuals in the U.S. grappling with this
The healthcare industry stands at a transformative juncture where artificial intelligence is redefining the boundaries of medical diagnostics, offering new hope for early detection and intervention. With chronic diseases often going undetected until symptoms become severe, the ability to predict
What happens when a seemingly harmless flu turns into a silent threat to your heart? Every year, millions battle common viruses like influenza or COVID-19, often shrugging them off as temporary inconveniences, yet beneath the surface, these infections may be laying the groundwork for something far
Imagine a silent saboteur lurking within the heart, contributing to its decline in ways that have gone unnoticed for decades until now, as cardiac fibroblasts, once thought to be mere structural support in the heart’s complex architecture, are now revealed as active participants in the progression
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert whose extensive experience in research and development, paired with a deep understanding of technology and innovation, has positioned him as a thought leader in the healthcare industry. Today, we’ll explore groundbreaking
